Optimel Manuka Forte Eye Gel

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of burning and irritation due to dryness of the eye. It serves as a protectant against further irritation and is effective in alleviating symptoms associated with dry eyes.

There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should ensure proper hygiene before administration by washing hands thoroughly. The cap of the medication should be removed carefully, taking care not to allow the nozzle to come into contact with any surfaces to maintain sterility.

For administration, the recommended dosage is to instill 1 drop into the inner corner of the affected eye. Alternatively, the medication may be dispensed onto the tip of a cotton bud, which can then be gently applied along the lower lid margin. This can be performed up to three times daily or as directed by a healthcare provider.

Contraindications

Use is contraindicated in patients with a known hypersensitivity to bee products or food gums. Additionally, the product should not be used if the solution exhibits any color change or cloudiness, if the box seal is broken or the packaging is damaged, or if the patient has serious conditions that require management under a physician's supervision.

Warnings and Precautions

For external use only. This product is not intended for ingestion. In the event of accidental swallowing, it is imperative to seek immediate medical assistance or contact a Poison Control Center.

Healthcare professionals should advise patients to discontinue use and consult a physician if they experience any of the following: eye pain or alterations in vision; persistent or worsening redness or irritation of the eye; symptoms that do not improve or worsen after 72 hours; or any adverse reactions beyond transient stinging and redness.

No specific laboratory tests are recommended for monitoring the use of this product. However, vigilance in observing the aforementioned symptoms is essential for ensuring patient safety and effective management of any potential adverse effects.

Side Effects

For external use only. Patients should discontinue use and consult a healthcare professional if they experience any of the following: eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours. Additionally, any reaction beyond transient stinging and redness warrants immediate medical attention. It is crucial for patients to monitor their symptoms closely and seek guidance if they encounter any concerning changes in their ocular health.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Optimel Manuka Forte Eye Gel (glycerin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The available prescribing information does not provide specific data regarding the use of this product during pregnancy. There are no contraindications noted for use in pregnant patients, nor are there any associated risks to the fetus identified in the available literature. Additionally, no dosage modifications or special precautions for use during pregnancy are mentioned. Healthcare professionals should consider the lack of data when prescribing this product to women of childbearing potential and weigh the potential benefits against any unknown risks.

Lactation

Nursing mothers should consult a healthcare professional before using this product. There is a potential for excretion in breast milk; therefore, caution is advised when administering to nursing mothers. The effects on the nursing infant are not well studied; thus, the risks versus benefits should be considered.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Patients should be evaluated for potential complications, and appropriate interventions should be implemented based on clinical judgment.

For further guidance, healthcare professionals may refer to established protocols for managing drug overdosage or consult a poison control center.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use the product if they are hypersensitive to bee products or food gums. Additionally, they should be cautioned against using the product if the solution changes color or becomes cloudy, if the box seal is broken, or if the packaging is damaged.

It is important for healthcare providers to emphasize that serious conditions should be managed under the supervision of a doctor. Patients should be instructed to stop using the product and consult a doctor if they experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours. They should also be advised to seek medical attention if they experience any reaction other than transient stinging and redness.

When using the product, patients should be reminded to avoid contamination by not touching the tip of the container to any surface and to replace the cap after use without overtightening it. Patients should also be instructed to remove contact lenses before application and to wait at least 10 minutes before reinserting them. It is normal for patients to experience initial stinging and redness upon application of the drops.

Storage and Handling

The product is supplied for single patient use only. It must be stored at temperatures below 25°C (77°F) to maintain its efficacy. After opening, the product should be discarded two months later to ensure safety and effectiveness.

Additional Clinical Information

Patients should instill 1 drop of the medication into the inner corner of the affected eye or apply it along the lower lid margin using a cotton bud, up to three times daily or as directed by a clinician. To prevent contamination, patients are advised not to touch the tip of the container to any surface, to replace the cap after use without overtightening, and to remove contact lenses prior to application. A waiting period of at least 10 minutes is recommended before reinserting contact lenses. Initial stinging and redness upon application are expected side effects.

Drug Information (PDF)

This file contains official product information for Optimel Manuka Forte Eye Gel, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)